Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KRYSTAL BIOTECH, INC.

(KRYS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

KRYSTAL BIOTECH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

05/24/2021 | 04:07pm EDT

Item 5.07 Submission of Matters to a Vote of Security Holders

At the Company's annual meeting of stockholders held on May 21, 2021 the matters submitted to a vote of stockholders were (i) the election of two Class I directors to the Board of Directors for a term expiring at the 2024 annual stockholders meeting, and (ii) the ratification of the selection of Mayer Hoffman McCann P.C as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021.

The following table sets forth the results of voting for the election of the Class I directors to the Board of Directors:



     Name          Votes For        Votes Withheld       Broker Non-Votes
Suma Krishnan       14,443,849            2,779,160              2,571,068
Julian Gangolli     14,926,119            2,296,890              2,571,068

The following table sets for the results of voting for the ratification of the appointment of Mayer Hoffman McCann P.C as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021.



Votes For     Votes Against       Abstentions
19,783,665             8,120             2,292

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about KRYSTAL BIOTECH, INC.
07/21NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
07/20KRYSTAL BIOTECH : Goldman Sachs Lifts Krystal Biotech to Buy From Neutral, Price..
MT
07/07KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
07/01KRYSTAL BIOTECH : Provides Update on the Clinical Trial Evaluating Topical KB105..
PU
07/01KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
07/01KRYSTAL BIOTECH : Reports Updated Data for Prospective Treatment of TGM-1 Associ..
MT
07/01Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB10..
GL
07/01Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB10..
CI
06/25KRYSTAL BIOTECH, INC.(NASDAQGM : KRYS) added to Russell Small Cap Comp Value Ind..
CI
06/25KRYSTAL BIOTECH, INC.(NASDAQGM : KRYS) added to Russell 3000E Value Index
CI
More news